Compare TECH & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | ACI |
|---|---|---|
| Founded | 1976 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.6B |
| IPO Year | 1989 | 2020 |
| Metric | TECH | ACI |
|---|---|---|
| Price | $65.12 | $16.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $70.46 | $24.29 |
| AVG Volume (30 Days) | 1.6M | ★ 9.0M |
| Earning Date | 02-04-2026 | 01-07-2026 |
| Dividend Yield | 0.49% | ★ 3.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.49 | ★ 1.54 |
| Revenue | $1,216,732,000.00 | ★ $81,719,800,000.00 |
| Revenue This Year | $2.33 | $4.87 |
| Revenue Next Year | $7.05 | $0.53 |
| P/E Ratio | $133.64 | ★ $10.47 |
| Revenue Growth | ★ 3.85 | 2.24 |
| 52 Week Low | $46.01 | $15.80 |
| 52 Week High | $79.28 | $23.20 |
| Indicator | TECH | ACI |
|---|---|---|
| Relative Strength Index (RSI) | 68.64 | 25.51 |
| Support Level | $58.40 | $16.93 |
| Resistance Level | $66.48 | $17.52 |
| Average True Range (ATR) | 1.57 | 0.39 |
| MACD | 0.78 | -0.06 |
| Stochastic Oscillator | 86.10 | 14.81 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 26% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.